HCM logo

HUTCHMED (China) Limited (HCM) Financials

Balance sheets

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202230 June 202131 Mar 202130 June 202031 Mar 2020

Total Assets

$1.3 B(-1.5%)$1.3 B(-1.4%)$1.3 B(+26.0%)$1.0 B(-13.8%)$1.2 B(-6.2%)$1.3 B(+83.7%)$693.1 M(+31.9%)$525.6 M-

Current Assets

$1.0 B(-4.4%)$1.1 B(+0.6%)$1.1 B(+29.8%)$839.9 M(-17.8%)$1.0 B(-6.3%)$1.1 B(+119.9%)$496.2 M(+32.4%)$374.7 M-

Non Current Assets

$212.6 M(+16.2%)$182.9 M(-11.6%)$207.0 M(+9.2%)$189.6 M(+10.2%)$172.1 M(-5.3%)$181.7 M(-7.7%)$196.9 M(+30.5%)$150.8 M-

Total Liabilities

$508.9 M(-5.1%)$536.4 M(+7.8%)$497.5 M(+26.7%)$392.6 M(+14.6%)$342.5 M(+32.1%)$259.2 M(+13.3%)$228.7 M(+44.3%)$158.5 M-

Current Liabilities

$401.4 M(-0.4%)$403.0 M(+18.2%)$340.9 M(-3.7%)$353.9 M(+10.0%)$321.9 M(+29.9%)$247.7 M(+31.4%)$188.5 M(+57.9%)$119.4 M-

Long Term Liabilities

$107.5 M(-19.4%)$133.4 M(-14.8%)$156.6 M(+305.0%)$38.7 M(+87.5%)$20.6 M(+79.7%)$11.5 M(-71.5%)$40.2 M(+2.8%)$39.1 M-

Shareholders Equity

$740.1 M(+1.3%)$730.5 M(-6.6%)$782.0 M(+28.1%)$610.4 M(-23.7%)$799.7 M(-18.8%)$984.8 M(+129.9%)$428.3 M(+25.2%)$342.1 M-

Book Value

$740.1 M(+1.3%)$730.5 M(-6.6%)$782.0 M(+28.1%)$610.4 M(-23.7%)$799.7 M(-18.8%)$984.8 M(+129.9%)$428.3 M(+25.2%)$342.1 M-

Working Capital

$646.9 M(-6.8%)$693.8 M(-7.5%)$749.6 M(+54.3%)$486.0 M(-30.6%)$700.4 M(-17.0%)$843.5 M(+174.1%)$307.7 M(+20.5%)$255.3 M-

Cash And Cash Equivalents

-$283.6 M(+27.2%)$223.0 M(-28.8%)$313.3 M(-33.0%)$467.5 M(-20.4%)$587.4 M(+69.7%)$346.1 M(+593.1%)$49.9 M-

Accounts Payable

$43.4 M(+19.5%)$36.3 M(-33.4%)$54.6 M(-23.3%)$71.1 M(+39.4%)$51.0 M(+78.9%)$28.5 M(-0.4%)$28.6 M(+10.7%)$25.9 M-

Accounts Receivable

$156.9 M(+36.5%)$115.0 M(-11.0%)$129.2 M(+36.8%)$94.5 M(+22.6%)$77.1 M(+33.0%)$58.0 M(+9.1%)$53.1 M(+19.1%)$44.6 M-

Short Term Debt

-$35.1 M-$3.7 M(+100.0%)$0.0(-100.0%)$30.7 M(+674.2%)$4.0 M(+53.0%)$2.6 M-

Long Term Debt

$82.1 M(+60.8%)$51.0 M(+27.2%)$40.1 M(+72.3%)$23.3 M(+5474.2%)$418.0 K(-93.0%)$6.0 M(-82.2%)$33.4 M(+10.9%)$30.1 M-

Total Debt

$82.1 M(-4.7%)$86.1 M(+114.5%)$40.1 M(+48.6%)$27.0 M(+6361.2%)$418.0 K(-98.9%)$36.7 M(-1.8%)$37.4 M(+14.3%)$32.7 M(+100.0%)$0.0

Debt To Equity

0.1(0%)0.1(+120.0%)0.1(+66.7%)0.0(+100.0%)0.0(-100.0%)0.0(-55.6%)0.1(-10.0%)0.1-

Current Ratio

2.6(-4.0%)2.7(-15.0%)3.2(+35.0%)2.4(-25.5%)3.2(-27.7%)4.4(+67.3%)2.6(-16.2%)3.1-

Quick Ratio

-2.6(-14.5%)3.0(+37.6%)2.2(-27.1%)3.0(-29.5%)4.3(+70.0%)2.5(-15.9%)3.0-

Inventory

-$50.3 M(-6.7%)$53.9 M(-5.0%)$56.7 M(+23.4%)$45.9 M(+80.1%)$25.5 M(+29.1%)$19.8 M(+29.4%)$15.3 M-

Retained Earnings

--$870.9 M(-8.4%)-$803.1 M(+17.3%)-$971.5 M(-25.6%)-$773.2 M(-49.3%)-$518.0 M(-13.4%)-$456.7 M(-34.5%)-$339.5 M-

PB Ratio

4.0-2.6(-36.4%)4.1(+53.2%)2.7(-60.6%)6.8(-29.6%)9.6(-13.7%)11.1-

Income statements

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202230 June 202131 Mar 202130 June 202031 Mar 2020

EPS

------$0.4(-33.3%)-$0.3(-20.0%)-$0.3(-150.0%)-$0.1

TTM EPS

------$0.7(-27.3%)-$0.6(-57.1%)-$0.3(-16.7%)-$0.3

Revenue

-----$75.8 M(-7.0%)$81.6 M(+47.8%)$55.2 M(+7.0%)$51.6 M

TTM Revenue

-----$157.4 M(+15.1%)$136.8 M(+28.1%)$106.8 M(+5.1%)$101.6 M

Total Expenses

-----$156.3 M(+8.0%)$144.8 M(+43.5%)$100.9 M(+20.0%)$84.1 M

Operating Expenses

-----$98.0 M(+22.8%)$79.8 M(+36.2%)$58.6 M(+37.0%)$42.8 M

Cost Of Goods Sold

-----$58.3 M(-10.2%)$64.9 M(+53.6%)$42.3 M(+2.4%)$41.3 M

TTM Cost Of Goods Sold

-----$123.2 M(+14.9%)$107.2 M(+28.3%)$83.6 M(+5.9%)$78.9 M

Gross Profit

-----$17.5 M(+5.3%)$16.6 M(+28.7%)$12.9 M(+25.6%)$10.3 M

TTM Gross Profit

-----$34.1 M(+15.5%)$29.5 M(+27.3%)$23.2 M(+2.3%)$22.7 M

Gross Margin

-----23.1%(+13.3%)20.4%(-12.9%)23.4%(+17.4%)19.9%

Operating Profit

------$80.5 M(-27.4%)-$63.2 M(-38.4%)-$45.7 M(-40.6%)-$32.5 M

TTM Operating Profit

------$143.7 M(-32.0%)-$108.9 M(-39.3%)-$78.2 M(-14.2%)-$68.5 M

Operating Margin

------106.2%(-37.1%)-77.5%(+6.4%)-82.8%(-31.3%)-63.0%

Net Income

------$61.3 M(-48.9%)-$41.1 M(-22.6%)-$33.6 M(-107.9%)-$16.1 M

TTM Net Income

------$102.4 M(-37.1%)-$74.7 M(-50.3%)-$49.7 M(-19.4%)-$41.6 M

Net Margin

------80.8%(-60.2%)-50.5%(+17.0%)-60.8%(-94.2%)-31.3%

EBIT

------$80.5 M(-27.4%)-$63.2 M(-38.4%)-$45.7 M(-40.6%)-$32.5 M

TTM EBIT

------$143.7 M(-32.0%)-$108.9 M(-39.3%)-$78.2 M(-14.2%)-$68.5 M

EBITDA

------$80.5 M(-27.4%)-$63.2 M(-38.4%)-$45.7 M(-40.6%)-$32.5 M

TTM EBITDA

------$143.7 M(-32.0%)-$108.9 M(-39.3%)-$78.2 M(-14.2%)-$68.5 M

Selling, General & Administrative Expenses

-----$32.0 M(+40.8%)$22.8 M(+50.5%)$15.1 M(+23.3%)$12.3 M

TTM SG&A

-----$54.8 M(+44.7%)$37.9 M(+38.3%)$27.4 M(+11.3%)$24.6 M

Depreciation And Amortization

-----$3.5 M-$2.9 M-

TTM D&A

-----$3.5 M-$2.9 M-

Interest Expense

---------

TTM Interest Expense

---------

Income Tax

------$80.0 K(-104.1%)$1.9 M(+96.5%)$987.0 K(-5.5%)$1.0 M

TTM Income Tax

-----$1.9 M(-36.5%)$2.9 M(+44.0%)$2.0 M(-7.5%)$2.2 M

PE Ratio

---------

PS Ratio

-----42.4(+40.8%)30.1(-15.7%)35.7(+47.0%)24.3

Cashflow statements

30 June 202431 Dec 202330 June 202331 Dec 202230 June 202230 June 202131 Mar 202130 June 202031 Mar 2020

Cash From Operations

------$49.0 M(-119.0%)-$22.4 M(+16.0%)-$26.6 M(-1415.0%)-$1.8 M

TTM CFO

------$71.3 M(-45.6%)-$49.0 M(-72.6%)-$28.4 M(-885.6%)-$2.9 M

Cash From Investing

------$315.9 M(-297.4%)$160.0 M(+487.7%)-$41.3 M(+57.8%)-$97.8 M

TTM CFI

------$155.9 M(-231.3%)$118.8 M(+185.4%)-$139.1 M(-87.8%)-$74.1 M

Cash From Financing

-----$605.1 M(+2362.2%)-$26.7 M(-86.3%)-$14.4 M(-113.0%)$110.7 M

TTM CFF

-----$578.3 M(+1507.1%)-$41.1 M(-142.7%)$96.3 M(+18.2%)$81.5 M

Free Cash Flow

------$51.8 M(-80.1%)-$28.8 M(-0.6%)-$28.6 M(-643.8%)-$3.8 M

TTM FCF

------$80.6 M(-40.5%)-$57.4 M(-76.8%)-$32.4 M(-335.2%)-$7.5 M

CAPEX

-----$2.9 M(-55.4%)$6.4 M(+225.3%)$2.0 M(-5.6%)$2.1 M

TTM CAPEX

-----$9.3 M(+10.6%)$8.4 M(+106.6%)$4.1 M(-11.3%)$4.6 M

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------